PRTFDC1 Inhibitors
PRTFDC1 inhibitors are chemical agents that specifically target and inhibit the function of the enzyme phosphoribosyltransferase domain containing 1 (PRTFDC1). This particular enzyme plays a key role in the purine metabolism pathway, which is a critical process for the synthesis and degradation of purine nucleotides. Purine nucleotides are essential components of cellular machinery, being the fundamental units of genetic material such as DNA and RNA. They are also involved in numerous cellular processes, including the storage and transfer of energy, as well as the formation of certain coenzymes. By inhibiting PRTFDC1, these chemical agents can alter the normal processing of these vital nucleotides within the cell.
The design of PRTFDC1 inhibitors is a highly precise and meticulous process that requires a deep understanding of the enzyme's structure. The active site of PRTFDC1, which is the region where substrate molecules bind and undergo chemical transformation, is the primary focus for the action of these inhibitors. When they bind to the active site, they obstruct the enzyme's natural substrates from entering and participating in the usual enzymatic reactions. This interaction is highly specific and involves a complex interplay of molecular forces and structural complementarity. Researchers endeavor to map out the enzyme's three-dimensional architecture with sophisticated techniques such as X-ray crystallography or NMR spectroscopy. This structural insight is crucial for the development of inhibitors that exhibit high specificity, ensuring they interact with the enzyme in a precise and effective manner.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin is a competitive inhibitor of purine and pyrimidine uptake, which may lead to a decreased availability of these nucleotides for the phosphoribosyltransferase function of PRTFDC1. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate acts as a dihydrofolate reductase inhibitor, leading to reduced production of tetrahydrofolate and subsequently purines and thymidylate. This reduction can indirectly affect PRTFDC1 activity by limiting its substrate availability. | ||||||
6-Mercaptopurine | 50-44-2 | sc-361087 sc-361087A | 50 mg 100 mg | $72.00 $104.00 | ||
6-Mercaptopurine is a purine analog that interferes with nucleotide synthesis and metabolism, potentially reducing the substrate pool for PRTFDC1’s enzymatic action. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, leading to decreased guanine nucleotide synthesis and indirectly downregulating PRTFDC1 activity due to reduced substrate availability. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Ribavirin is a nucleoside analog that inhibits inosine monophosphate dehydrogenase, which could lead to a decrease in guanine nucleotide pools, indirectly affecting PRTFDC1 activity. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, decreasing the deoxyribonucleotide pools necessary for DNA synthesis, which may indirectly decrease the need for PRTFDC1’s function in nucleotide metabolism. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Allopurinol is a xanthine oxidase inhibitor that decreases the production of uric acid from purines, which could indirectly lead to altered purine metabolism and reduced PRTFDC1 activity. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
Azathioprine is metabolized to 6-mercaptopurine, interfering with purine nucleotide synthesis and potentially reducing PRTFDC1 activity indirectly through limited substrate availability. | ||||||
Tiazofurin | 60084-10-8 | sc-475805 | 5 mg | $449.00 | ||
Tiazofurin inhibits IMP dehydrogenase, leading to decreased levels of guanine nucleotides and potentially affecting the activity of PRTFDC1 indirectly by reducing its substrate pool. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $58.00 $204.00 | 15 | |
Fludarabine is a nucleotide analog that inhibits DNA synthesis and can indirectly decrease PRTFDC1 activity by interfering with the availability of its substrates. | ||||||